Nomogram predicting the prognosis of primary liver cancer after radiofrequency ablation combined with transcatheter arterial chemoembolization

doi:10.4240/wjgs.v16.i8.2630

Advanced Search

BPG is committed to discovery and dissemination of knowledge

Home / Archive / Volume 16, Issue 8

This Article

Academic Content and Language Evaluation of This Article

CrossCheck and Google Search of This Article

Academic Rules and Norms of This Article

Citation of this article

Corresponding Author of This Article

Research Domain of This Article

Article-Type of This Article

Open-Access Policy of This Article

Times Cited Counts in Google of This Article

Number of Hits and Downloads for This Article

Total Article Views (1226)

All Articles published online

The chart showing PDF series, WORD series, HTML series, Figures (1-4) series, Tables (1-2) series.

Item

Count

PDF

WORD

HTML

645

Figures (1-4)

131

Tables (1-2)

147

Sum=965

Publishing Process of This Article

The chart showing Browse series, Download series.

Item

Count

Browse

Download

154

Sum=225

Aug 27, 2024 (publication date) through Feb 3, 2025

Times Cited of This Article

Times Cited (1)

Journal Information of This Article

Publication Name

World Journal of Gastrointestinal Surgery

ISSN

1948-9366

Publisher of This Article

Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA

Observational Study

World J Gastrointest Surg. Aug 27, 2024; 16(8): 2630-2639
Published online Aug 27, 2024. doi: 10.4240/wjgs.v16.i8.2630

Full Size Figure Download Figure

Figure 1 Nomogram prediction model for the prognosis of patients with hepatocellular carcinoma treated with radiofrequency ablation and transcatheter arterial chemoembolization. HCC: Hepatocellular carcinoma; RFA: Radiofrequency ablation; AFP: Alpha-fetoprotein; AFU: α-L-fucosidase; PNI: Prognostic nutritional index.

Citation: Shen HH, Hong YR, Xu W, Chen L, Chen JM, Yang ZG, Chen CH. Nomogram predicting the prognosis of primary liver cancer after radiofrequency ablation combined with transcatheter arterial chemoembolization. World J Gastrointest Surg 2024; 16(8): 2630-2639
URL: https://www.wjgnet.com/1948-9366/full/v16/i8/2630.htm
DOI: https://dx.doi.org/10.4240/wjgs.v16.i8.2630